Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) Stock Competitors & Peer Comparison
See ADVENZYMES.NS's competitors and their performance on the NSE and across the wider stock market.
Peer Comparison Table: Chemicals - Specialty Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ADVENZYMES.NS and its NSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ADVENZYMES.NS | ₹317.35 | +0.99% | 35.5B | 25.57 | ₹12.41 | +0.43% |
| ASIANPAINT.BO | ₹2,638.30 | -1.15% | 2.5T | 58.50 | ₹45.10 | +1.04% |
| ASIANPAINT.NS | ₹2,637.90 | -1.16% | 2.5T | 58.50 | ₹45.09 | +1.04% |
| SOLARINDS.BO | ₹18,489.15 | -0.64% | 1.7T | 99.76 | ₹185.34 | +0.05% |
| SOLARINDS.NS | ₹18,494.00 | -0.68% | 1.7T | 99.76 | ₹185.38 | +0.05% |
| PIDILITIND.NS | ₹1,570.90 | +0.43% | 1.6T | 64.91 | ₹24.20 | +1.05% |
| PIDILITIND.BO | ₹1,570.90 | +0.40% | 1.6T | 64.91 | ₹24.20 | +1.05% |
| SRF.NS | ₹2,664.70 | +1.60% | 789.9B | 43.06 | ₹61.89 | +0.34% |
| SRF.BO | ₹2,661.20 | +1.49% | 789.9B | 42.98 | ₹61.91 | +0.34% |
| BERGEPAINT.NS | ₹497.95 | +0.88% | 580.6B | 47.88 | ₹10.40 | +0.76% |
Stock Comparison
Asian Paints Limited (BSE: ASIANPAINT.BO)
ADVENZYMES.NS vs ASIANPAINT.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ASIANPAINT.BO has a market cap of 2.5T. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ASIANPAINT.BO trades at ₹2,638.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ASIANPAINT.BO's P/E ratio is 58.50. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ASIANPAINT.BO's ROE of +0.21%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to ASIANPAINT.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ASIANPAINT.BO's competition here
Asian Paints Limited (NSE: ASIANPAINT.NS)
ADVENZYMES.NS vs ASIANPAINT.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ASIANPAINT.NS has a market cap of 2.5T. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ASIANPAINT.NS trades at ₹2,637.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ASIANPAINT.NS's P/E ratio is 58.50. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ASIANPAINT.NS's ROE of +0.21%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to ASIANPAINT.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ASIANPAINT.NS's competition here
Solar Industries India Limited (BSE: SOLARINDS.BO)
ADVENZYMES.NS vs SOLARINDS.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, SOLARINDS.BO has a market cap of 1.7T. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while SOLARINDS.BO trades at ₹18,489.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas SOLARINDS.BO's P/E ratio is 99.76. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to SOLARINDS.BO's ROE of +0.32%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to SOLARINDS.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check SOLARINDS.BO's competition here
Solar Industries India Limited (NSE: SOLARINDS.NS)
ADVENZYMES.NS vs SOLARINDS.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, SOLARINDS.NS has a market cap of 1.7T. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while SOLARINDS.NS trades at ₹18,494.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas SOLARINDS.NS's P/E ratio is 99.76. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to SOLARINDS.NS's ROE of +0.32%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to SOLARINDS.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check SOLARINDS.NS's competition here
Pidilite Industries Limited (NSE: PIDILITIND.NS)
ADVENZYMES.NS vs PIDILITIND.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, PIDILITIND.NS has a market cap of 1.6T. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while PIDILITIND.NS trades at ₹1,570.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas PIDILITIND.NS's P/E ratio is 64.91. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to PIDILITIND.NS's ROE of +0.24%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to PIDILITIND.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check PIDILITIND.NS's competition here
Pidilite Industries Limited (BSE: PIDILITIND.BO)
ADVENZYMES.NS vs PIDILITIND.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, PIDILITIND.BO has a market cap of 1.6T. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while PIDILITIND.BO trades at ₹1,570.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas PIDILITIND.BO's P/E ratio is 64.91. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to PIDILITIND.BO's ROE of +0.24%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to PIDILITIND.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check PIDILITIND.BO's competition here
SRF Limited (NSE: SRF.NS)
ADVENZYMES.NS vs SRF.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, SRF.NS has a market cap of 789.9B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while SRF.NS trades at ₹2,664.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas SRF.NS's P/E ratio is 43.06. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to SRF.NS's ROE of +0.16%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to SRF.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check SRF.NS's competition here
SRF Limited (BSE: SRF.BO)
ADVENZYMES.NS vs SRF.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, SRF.BO has a market cap of 789.9B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while SRF.BO trades at ₹2,661.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas SRF.BO's P/E ratio is 42.98. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to SRF.BO's ROE of +0.16%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to SRF.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check SRF.BO's competition here
Berger Paints India Limited (NSE: BERGEPAINT.NS)
ADVENZYMES.NS vs BERGEPAINT.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, BERGEPAINT.NS has a market cap of 580.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while BERGEPAINT.NS trades at ₹497.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas BERGEPAINT.NS's P/E ratio is 47.88. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to BERGEPAINT.NS's ROE of +0.18%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to BERGEPAINT.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check BERGEPAINT.NS's competition here
Berger Paints India Limited (BSE: BERGEPAINT.BO)
ADVENZYMES.NS vs BERGEPAINT.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, BERGEPAINT.BO has a market cap of 580.3B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while BERGEPAINT.BO trades at ₹497.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas BERGEPAINT.BO's P/E ratio is 47.87. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to BERGEPAINT.BO's ROE of +0.18%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to BERGEPAINT.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check BERGEPAINT.BO's competition here
Linde India Limited (BSE: LINDEINDIA.BO)
ADVENZYMES.NS vs LINDEINDIA.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, LINDEINDIA.BO has a market cap of 574.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while LINDEINDIA.BO trades at ₹6,735.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas LINDEINDIA.BO's P/E ratio is 104.91. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to LINDEINDIA.BO's ROE of +0.14%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to LINDEINDIA.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check LINDEINDIA.BO's competition here
Linde India Limited (NSE: LINDEINDIA.NS)
ADVENZYMES.NS vs LINDEINDIA.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, LINDEINDIA.NS has a market cap of 574B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while LINDEINDIA.NS trades at ₹6,731.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas LINDEINDIA.NS's P/E ratio is 120.67. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to LINDEINDIA.NS's ROE of +0.14%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to LINDEINDIA.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check LINDEINDIA.NS's competition here
Gujarat Fluorochemicals Limited (NSE: FLUOROCHEM.NS)
ADVENZYMES.NS vs FLUOROCHEM.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, FLUOROCHEM.NS has a market cap of 502.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while FLUOROCHEM.NS trades at ₹4,573.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas FLUOROCHEM.NS's P/E ratio is 85.27. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to FLUOROCHEM.NS's ROE of +0.08%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to FLUOROCHEM.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check FLUOROCHEM.NS's competition here
Gujarat Fluorochemicals Limited (BSE: FLUOROCHEM.BO)
ADVENZYMES.NS vs FLUOROCHEM.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, FLUOROCHEM.BO has a market cap of 502.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while FLUOROCHEM.BO trades at ₹4,597.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas FLUOROCHEM.BO's P/E ratio is 85.57. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to FLUOROCHEM.BO's ROE of +0.08%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to FLUOROCHEM.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check FLUOROCHEM.BO's competition here
Himadri Speciality Chemical Limited (NSE: HSCL.NS)
ADVENZYMES.NS vs HSCL.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, HSCL.NS has a market cap of 398.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while HSCL.NS trades at ₹789.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas HSCL.NS's P/E ratio is 53.46. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to HSCL.NS's ROE of +0.19%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to HSCL.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check HSCL.NS's competition here
Himadri Speciality Chemical Limited (BSE: HSCL.BO)
ADVENZYMES.NS vs HSCL.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, HSCL.BO has a market cap of 398.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while HSCL.BO trades at ₹789.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas HSCL.BO's P/E ratio is 51.79. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to HSCL.BO's ROE of +0.19%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to HSCL.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check HSCL.BO's competition here
Navin Fluorine International Limited (NSE: NAVINFLUOR.NS)
ADVENZYMES.NS vs NAVINFLUOR.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, NAVINFLUOR.NS has a market cap of 385.7B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while NAVINFLUOR.NS trades at ₹7,520.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas NAVINFLUOR.NS's P/E ratio is 56.92. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to NAVINFLUOR.NS's ROE of +0.19%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to NAVINFLUOR.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check NAVINFLUOR.NS's competition here
Navin Fluorine International Limited (BSE: NAVINFLUOR.BO)
ADVENZYMES.NS vs NAVINFLUOR.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, NAVINFLUOR.BO has a market cap of 385.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while NAVINFLUOR.BO trades at ₹7,525.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas NAVINFLUOR.BO's P/E ratio is 56.96. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to NAVINFLUOR.BO's ROE of +0.19%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to NAVINFLUOR.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check NAVINFLUOR.BO's competition here
Acutaas Chemicals Ltd. (NSE: ACUTAAS.NS)
ADVENZYMES.NS vs ACUTAAS.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ACUTAAS.NS has a market cap of 266.9B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ACUTAAS.NS trades at ₹3,259.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ACUTAAS.NS's P/E ratio is 85.62. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ACUTAAS.NS's ROE of +0.25%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to ACUTAAS.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ACUTAAS.NS's competition here
Acutaas Chemicals Limited (BSE: ACUTAAS.BO)
ADVENZYMES.NS vs ACUTAAS.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ACUTAAS.BO has a market cap of 266.7B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ACUTAAS.BO trades at ₹3,257.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ACUTAAS.BO's P/E ratio is 75.68. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ACUTAAS.BO's ROE of +0.08%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to ACUTAAS.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ACUTAAS.BO's competition here
Aether Industries Limited (NSE: AETHER.NS)
ADVENZYMES.NS vs AETHER.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, AETHER.NS has a market cap of 189.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while AETHER.NS trades at ₹1,427.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas AETHER.NS's P/E ratio is 84.77. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to AETHER.NS's ROE of +0.09%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to AETHER.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check AETHER.NS's competition here
Atul Ltd (BSE: ATUL.BO)
ADVENZYMES.NS vs ATUL.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ATUL.BO has a market cap of 189.3B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ATUL.BO trades at ₹6,394.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ATUL.BO's P/E ratio is 27.63. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ATUL.BO's ROE of +0.11%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to ATUL.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ATUL.BO's competition here
Atul Ltd (NSE: ATUL.NS)
ADVENZYMES.NS vs ATUL.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ATUL.NS has a market cap of 188.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ATUL.NS trades at ₹6,407.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ATUL.NS's P/E ratio is 27.76. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ATUL.NS's ROE of +0.11%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to ATUL.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ATUL.NS's competition here
Aether Industries Limited (BSE: AETHER.BO)
ADVENZYMES.NS vs AETHER.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, AETHER.BO has a market cap of 188.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while AETHER.BO trades at ₹1,428.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas AETHER.BO's P/E ratio is 85.67. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to AETHER.BO's ROE of +0.09%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to AETHER.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check AETHER.BO's competition here
Aarti Industries Limited (NSE: AARTIIND.NS)
ADVENZYMES.NS vs AARTIIND.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, AARTIIND.NS has a market cap of 173.3B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while AARTIIND.NS trades at ₹477.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas AARTIIND.NS's P/E ratio is 40.12. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to AARTIIND.NS's ROE of +0.07%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to AARTIIND.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check AARTIIND.NS's competition here
Aarti Industries Limited (BSE: AARTIIND.BO)
ADVENZYMES.NS vs AARTIIND.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, AARTIIND.BO has a market cap of 173B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while AARTIIND.BO trades at ₹477.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas AARTIIND.BO's P/E ratio is 40.08. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to AARTIIND.BO's ROE of +0.07%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to AARTIIND.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check AARTIIND.BO's competition here
Garware Hi-Tech Films Limited (NSE: GRWRHITECH.NS)
ADVENZYMES.NS vs GRWRHITECH.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, GRWRHITECH.NS has a market cap of 160.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while GRWRHITECH.NS trades at ₹6,903.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas GRWRHITECH.NS's P/E ratio is 47.42. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to GRWRHITECH.NS's ROE of +0.13%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to GRWRHITECH.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check GRWRHITECH.NS's competition here
Garware Hi-Tech Films Limited (BSE: GRWRHITECH.BO)
ADVENZYMES.NS vs GRWRHITECH.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, GRWRHITECH.BO has a market cap of 160.2B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while GRWRHITECH.BO trades at ₹6,906.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas GRWRHITECH.BO's P/E ratio is 53.02. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to GRWRHITECH.BO's ROE of +0.13%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to GRWRHITECH.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check GRWRHITECH.BO's competition here
BASF India Limited (NSE: BASF.NS)
ADVENZYMES.NS vs BASF.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, BASF.NS has a market cap of 158.9B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while BASF.NS trades at ₹3,670.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas BASF.NS's P/E ratio is 38.45. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to BASF.NS's ROE of +0.11%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to BASF.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check BASF.NS's competition here
BASF India Limited (BSE: BASF.BO)
ADVENZYMES.NS vs BASF.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, BASF.BO has a market cap of 158.7B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while BASF.BO trades at ₹3,670.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas BASF.BO's P/E ratio is 39.08. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to BASF.BO's ROE of +0.11%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to BASF.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check BASF.BO's competition here
Kansai Nerolac Paints Limited (BSE: KANSAINER.BO)
ADVENZYMES.NS vs KANSAINER.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, KANSAINER.BO has a market cap of 156.9B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while KANSAINER.BO trades at ₹193.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas KANSAINER.BO's P/E ratio is 24.29. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to KANSAINER.BO's ROE of +0.09%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to KANSAINER.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check KANSAINER.BO's competition here
Kansai Nerolac Paints Limited (NSE: KANSAINER.NS)
ADVENZYMES.NS vs KANSAINER.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, KANSAINER.NS has a market cap of 156.2B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while KANSAINER.NS trades at ₹193.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas KANSAINER.NS's P/E ratio is 24.30. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to KANSAINER.NS's ROE of +0.09%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to KANSAINER.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check KANSAINER.NS's competition here
Fine Organic Industries Limited (BSE: FINEORG.BO)
ADVENZYMES.NS vs FINEORG.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, FINEORG.BO has a market cap of 148.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while FINEORG.BO trades at ₹4,831.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas FINEORG.BO's P/E ratio is 36.06. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to FINEORG.BO's ROE of +0.17%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to FINEORG.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check FINEORG.BO's competition here
Fine Organic Industries Limited (NSE: FINEORG.NS)
ADVENZYMES.NS vs FINEORG.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, FINEORG.NS has a market cap of 148B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while FINEORG.NS trades at ₹4,828.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas FINEORG.NS's P/E ratio is 37.81. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to FINEORG.NS's ROE of +0.17%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to FINEORG.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check FINEORG.NS's competition here
Anupam Rasayan India Limited (BSE: ANURAS.BO)
ADVENZYMES.NS vs ANURAS.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ANURAS.BO has a market cap of 142.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ANURAS.BO trades at ₹1,249.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ANURAS.BO's P/E ratio is 82.56. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ANURAS.BO's ROE of +0.05%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to ANURAS.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ANURAS.BO's competition here
Anupam Rasayan India Limited (NSE: ANURAS.NS)
ADVENZYMES.NS vs ANURAS.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ANURAS.NS has a market cap of 142.3B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ANURAS.NS trades at ₹1,249.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ANURAS.NS's P/E ratio is 96.87. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ANURAS.NS's ROE of +0.05%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to ANURAS.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ANURAS.NS's competition here
Privi Speciality Chemicals Limited (BSE: PRIVISCL.BO)
ADVENZYMES.NS vs PRIVISCL.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, PRIVISCL.BO has a market cap of 140.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while PRIVISCL.BO trades at ₹3,595.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas PRIVISCL.BO's P/E ratio is 42.88. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to PRIVISCL.BO's ROE of +0.26%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to PRIVISCL.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check PRIVISCL.BO's competition here
Privi Speciality Chemicals Limited (NSE: PRIVISCL.NS)
ADVENZYMES.NS vs PRIVISCL.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, PRIVISCL.NS has a market cap of 140.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while PRIVISCL.NS trades at ₹3,595.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas PRIVISCL.NS's P/E ratio is 42.88. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to PRIVISCL.NS's ROE of +0.26%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to PRIVISCL.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check PRIVISCL.NS's competition here
Shaily Engineering Plastics Limited (NSE: SHAILY.NS)
ADVENZYMES.NS vs SHAILY.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, SHAILY.NS has a market cap of 136.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while SHAILY.NS trades at ₹2,969.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas SHAILY.NS's P/E ratio is 95.12. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to SHAILY.NS's ROE of +0.27%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to SHAILY.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check SHAILY.NS's competition here
Shaily Engineering Plastics Limited (BSE: SHAILY.BO)
ADVENZYMES.NS vs SHAILY.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, SHAILY.BO has a market cap of 136.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while SHAILY.BO trades at ₹2,950.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas SHAILY.BO's P/E ratio is 79.96. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to SHAILY.BO's ROE of +0.27%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to SHAILY.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check SHAILY.BO's competition here
Akzo Nobel India Limited (NSE: AKZOINDIA.NS)
ADVENZYMES.NS vs AKZOINDIA.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, AKZOINDIA.NS has a market cap of 136B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while AKZOINDIA.NS trades at ₹2,986.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas AKZOINDIA.NS's P/E ratio is 6.95. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to AKZOINDIA.NS's ROE of +1.07%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to AKZOINDIA.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check AKZOINDIA.NS's competition here
Akzo Nobel India Limited (BSE: AKZOINDIA.BO)
ADVENZYMES.NS vs AKZOINDIA.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, AKZOINDIA.BO has a market cap of 136B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while AKZOINDIA.BO trades at ₹2,985.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas AKZOINDIA.BO's P/E ratio is 6.95. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to AKZOINDIA.BO's ROE of +1.07%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to AKZOINDIA.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check AKZOINDIA.BO's competition here
Vinati Organics Limited (NSE: VINATIORGA.NS)
ADVENZYMES.NS vs VINATIORGA.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, VINATIORGA.NS has a market cap of 134.8B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while VINATIORGA.NS trades at ₹1,300.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas VINATIORGA.NS's P/E ratio is 30.34. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to VINATIORGA.NS's ROE of +0.15%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to VINATIORGA.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check VINATIORGA.NS's competition here
Vinati Organics Limited (BSE: VINATIORGA.BO)
ADVENZYMES.NS vs VINATIORGA.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, VINATIORGA.BO has a market cap of 134.8B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while VINATIORGA.BO trades at ₹1,301.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas VINATIORGA.BO's P/E ratio is 30.36. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to VINATIORGA.BO's ROE of +0.15%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to VINATIORGA.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check VINATIORGA.BO's competition here
PCBL Limited (NSE: PCBL.NS)
ADVENZYMES.NS vs PCBL.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, PCBL.NS has a market cap of 125.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while PCBL.NS trades at ₹317.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas PCBL.NS's P/E ratio is 61.37. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to PCBL.NS's ROE of +0.05%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to PCBL.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check PCBL.NS's competition here
PCBL Limited (BSE: PCBL.BO)
ADVENZYMES.NS vs PCBL.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, PCBL.BO has a market cap of 124.9B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while PCBL.BO trades at ₹317.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas PCBL.BO's P/E ratio is 61.09. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to PCBL.BO's ROE of +0.05%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to PCBL.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check PCBL.BO's competition here
Jubilant Ingrevia Limited (NSE: JUBLINGREA.NS)
ADVENZYMES.NS vs JUBLINGREA.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, JUBLINGREA.NS has a market cap of 114.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while JUBLINGREA.NS trades at ₹725.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas JUBLINGREA.NS's P/E ratio is 40.02. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to JUBLINGREA.NS's ROE of +0.10%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to JUBLINGREA.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check JUBLINGREA.NS's competition here
Jubilant Ingrevia Limited (BSE: JUBLINGREA.BO)
ADVENZYMES.NS vs JUBLINGREA.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, JUBLINGREA.BO has a market cap of 114.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while JUBLINGREA.BO trades at ₹725.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas JUBLINGREA.BO's P/E ratio is 39.75. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to JUBLINGREA.BO's ROE of +0.10%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to JUBLINGREA.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check JUBLINGREA.BO's competition here
Ami Organics Limited (NSE: AMIORG.NS)
ADVENZYMES.NS vs AMIORG.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, AMIORG.NS has a market cap of 96.3B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while AMIORG.NS trades at ₹1,176.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas AMIORG.NS's P/E ratio is 119.06. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to AMIORG.NS's ROE of +0.08%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to AMIORG.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check AMIORG.NS's competition here
Ami Organics Limited (BSE: AMIORG.BO)
ADVENZYMES.NS vs AMIORG.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, AMIORG.BO has a market cap of 96.3B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while AMIORG.BO trades at ₹1,176.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas AMIORG.BO's P/E ratio is 118.95. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to AMIORG.BO's ROE of +0.08%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to AMIORG.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check AMIORG.BO's competition here
Alkyl Amines Chemicals Limited (NSE: ALKYLAMINE.NS)
ADVENZYMES.NS vs ALKYLAMINE.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ALKYLAMINE.NS has a market cap of 91.5B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ALKYLAMINE.NS trades at ₹1,789.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ALKYLAMINE.NS's P/E ratio is 51.57. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ALKYLAMINE.NS's ROE of +0.12%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to ALKYLAMINE.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ALKYLAMINE.NS's competition here
Alkyl Amines Chemicals Limited (BSE: ALKYLAMINE.BO)
ADVENZYMES.NS vs ALKYLAMINE.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ALKYLAMINE.BO has a market cap of 91.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ALKYLAMINE.BO trades at ₹1,780.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ALKYLAMINE.BO's P/E ratio is 50.89. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ALKYLAMINE.BO's ROE of +0.12%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to ALKYLAMINE.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ALKYLAMINE.BO's competition here
Sudarshan Chemical Industries Limited (NSE: SUDARSCHEM.NS)
ADVENZYMES.NS vs SUDARSCHEM.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, SUDARSCHEM.NS has a market cap of 81.9B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while SUDARSCHEM.NS trades at ₹1,041.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas SUDARSCHEM.NS's P/E ratio is 117.63. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to SUDARSCHEM.NS's ROE of +0.01%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to SUDARSCHEM.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check SUDARSCHEM.NS's competition here
Sudarshan Chemical Industries Limited (BSE: SUDARSCHEM.BO)
ADVENZYMES.NS vs SUDARSCHEM.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, SUDARSCHEM.BO has a market cap of 81.8B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while SUDARSCHEM.BO trades at ₹1,042.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas SUDARSCHEM.BO's P/E ratio is 106.33. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to SUDARSCHEM.BO's ROE of +0.01%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to SUDARSCHEM.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check SUDARSCHEM.BO's competition here
India Glycols Limited (NSE: INDIAGLYCO.NS)
ADVENZYMES.NS vs INDIAGLYCO.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, INDIAGLYCO.NS has a market cap of 77.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while INDIAGLYCO.NS trades at ₹1,157.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas INDIAGLYCO.NS's P/E ratio is 25.65. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to INDIAGLYCO.NS's ROE of +0.12%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to INDIAGLYCO.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check INDIAGLYCO.NS's competition here
Clean Science and Technology Limited (NSE: CLEAN.NS)
ADVENZYMES.NS vs CLEAN.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, CLEAN.NS has a market cap of 76.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while CLEAN.NS trades at ₹721.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas CLEAN.NS's P/E ratio is 32.80. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to CLEAN.NS's ROE of +0.15%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to CLEAN.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check CLEAN.NS's competition here
Clean Science and Technology Limited (BSE: CLEAN.BO)
ADVENZYMES.NS vs CLEAN.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, CLEAN.BO has a market cap of 76.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while CLEAN.BO trades at ₹720.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas CLEAN.BO's P/E ratio is 33.38. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to CLEAN.BO's ROE of +0.15%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to CLEAN.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check CLEAN.BO's competition here
Elantas Beck India Limited (BSE: ELANTAS.BO)
ADVENZYMES.NS vs ELANTAS.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ELANTAS.BO has a market cap of 73.8B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ELANTAS.BO trades at ₹9,310.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ELANTAS.BO's P/E ratio is 50.55. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ELANTAS.BO's ROE of +0.15%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to ELANTAS.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ELANTAS.BO's competition here
Balaji Amines Limited (BSE: BALAMINES.BO)
ADVENZYMES.NS vs BALAMINES.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, BALAMINES.BO has a market cap of 70.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while BALAMINES.BO trades at ₹2,181.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas BALAMINES.BO's P/E ratio is 40.12. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to BALAMINES.BO's ROE of +0.08%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to BALAMINES.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check BALAMINES.BO's competition here
Kingfa Science & Technology (India) Limited (NSE: KINGFA.NS)
ADVENZYMES.NS vs KINGFA.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, KINGFA.NS has a market cap of 70.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while KINGFA.NS trades at ₹5,212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas KINGFA.NS's P/E ratio is 37.17. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to KINGFA.NS's ROE of +0.16%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to KINGFA.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check KINGFA.NS's competition here
Kingfa Science & Technology (India) Limited (BSE: KINGFA.BO)
ADVENZYMES.NS vs KINGFA.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, KINGFA.BO has a market cap of 70.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while KINGFA.BO trades at ₹5,228.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas KINGFA.BO's P/E ratio is 37.29. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to KINGFA.BO's ROE of +0.16%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to KINGFA.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check KINGFA.BO's competition here
Balaji Amines Limited (NSE: BALAMINES.NS)
ADVENZYMES.NS vs BALAMINES.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, BALAMINES.NS has a market cap of 70.5B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while BALAMINES.NS trades at ₹2,174.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas BALAMINES.NS's P/E ratio is 40.00. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to BALAMINES.NS's ROE of +0.08%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to BALAMINES.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check BALAMINES.NS's competition here
Galaxy Surfactants Limited (NSE: GALAXYSURF.NS)
ADVENZYMES.NS vs GALAXYSURF.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, GALAXYSURF.NS has a market cap of 69B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while GALAXYSURF.NS trades at ₹1,945.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas GALAXYSURF.NS's P/E ratio is 24.83. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to GALAXYSURF.NS's ROE of +0.11%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to GALAXYSURF.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check GALAXYSURF.NS's competition here
Galaxy Surfactants Limited (BSE: GALAXYSURF.BO)
ADVENZYMES.NS vs GALAXYSURF.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, GALAXYSURF.BO has a market cap of 68.7B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while GALAXYSURF.BO trades at ₹1,933.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas GALAXYSURF.BO's P/E ratio is 24.69. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to GALAXYSURF.BO's ROE of +0.11%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to GALAXYSURF.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check GALAXYSURF.BO's competition here
Tanfac Industries Limited (BSE: TANFACIND.BO)
ADVENZYMES.NS vs TANFACIND.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, TANFACIND.BO has a market cap of 57.3B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while TANFACIND.BO trades at ₹2,702.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas TANFACIND.BO's P/E ratio is 73.86. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to TANFACIND.BO's ROE of +0.21%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to TANFACIND.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check TANFACIND.BO's competition here
Neogen Chemicals Limited (NSE: NEOGEN.NS)
ADVENZYMES.NS vs NEOGEN.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, NEOGEN.NS has a market cap of 54.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while NEOGEN.NS trades at ₹2,062.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas NEOGEN.NS's P/E ratio is 187.19. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to NEOGEN.NS's ROE of +0.04%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to NEOGEN.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check NEOGEN.NS's competition here
Neogen Chemicals Limited (BSE: NEOGEN.BO)
ADVENZYMES.NS vs NEOGEN.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, NEOGEN.BO has a market cap of 54.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while NEOGEN.BO trades at ₹2,063.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas NEOGEN.BO's P/E ratio is 189.47. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to NEOGEN.BO's ROE of +0.04%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to NEOGEN.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check NEOGEN.BO's competition here
Laxmi Organic Industries Limited (NSE: LXCHEM.NS)
ADVENZYMES.NS vs LXCHEM.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, LXCHEM.NS has a market cap of 50.5B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while LXCHEM.NS trades at ₹182.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas LXCHEM.NS's P/E ratio is 62.70. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to LXCHEM.NS's ROE of +0.04%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to LXCHEM.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check LXCHEM.NS's competition here
Laxmi Organic Industries Limited (BSE: LXCHEM.BO)
ADVENZYMES.NS vs LXCHEM.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, LXCHEM.BO has a market cap of 50.5B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while LXCHEM.BO trades at ₹182.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas LXCHEM.BO's P/E ratio is 62.70. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to LXCHEM.BO's ROE of +0.04%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to LXCHEM.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check LXCHEM.BO's competition here
Indigo Paints Limited (NSE: INDIGOPNTS.NS)
ADVENZYMES.NS vs INDIGOPNTS.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, INDIGOPNTS.NS has a market cap of 50B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while INDIGOPNTS.NS trades at ₹1,048.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas INDIGOPNTS.NS's P/E ratio is 33.27. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to INDIGOPNTS.NS's ROE of +0.13%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to INDIGOPNTS.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check INDIGOPNTS.NS's competition here
Indigo Paints Limited (BSE: INDIGOPNTS.BO)
ADVENZYMES.NS vs INDIGOPNTS.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, INDIGOPNTS.BO has a market cap of 49.9B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while INDIGOPNTS.BO trades at ₹1,046.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas INDIGOPNTS.BO's P/E ratio is 33.20. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to INDIGOPNTS.BO's ROE of +0.13%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to INDIGOPNTS.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check INDIGOPNTS.BO's competition here
Responsive Industries Limited (NSE: RESPONIND.NS)
ADVENZYMES.NS vs RESPONIND.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, RESPONIND.NS has a market cap of 46.9B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while RESPONIND.NS trades at ₹176.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas RESPONIND.NS's P/E ratio is 26.47. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to RESPONIND.NS's ROE of +0.10%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to RESPONIND.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check RESPONIND.NS's competition here
Responsive Industries Limited (BSE: RESPONIND.BO)
ADVENZYMES.NS vs RESPONIND.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, RESPONIND.BO has a market cap of 46.8B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while RESPONIND.BO trades at ₹175.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas RESPONIND.BO's P/E ratio is 22.93. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to RESPONIND.BO's ROE of +0.10%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to RESPONIND.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check RESPONIND.BO's competition here
Savita Oil Technologies Limited (BSE: SOTL.BO)
ADVENZYMES.NS vs SOTL.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, SOTL.BO has a market cap of 44.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while SOTL.BO trades at ₹646.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas SOTL.BO's P/E ratio is 24.39. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to SOTL.BO's ROE of +0.10%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to SOTL.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check SOTL.BO's competition here
Savita Oil Technologies Limited (NSE: SOTL.NS)
ADVENZYMES.NS vs SOTL.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, SOTL.NS has a market cap of 44.3B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while SOTL.NS trades at ₹645.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas SOTL.NS's P/E ratio is 24.35. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to SOTL.NS's ROE of +0.10%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to SOTL.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check SOTL.NS's competition here
Vishnu Chemicals Limited (NSE: VISHNU.NS)
ADVENZYMES.NS vs VISHNU.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, VISHNU.NS has a market cap of 42.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while VISHNU.NS trades at ₹632.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas VISHNU.NS's P/E ratio is 31.00. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to VISHNU.NS's ROE of +0.14%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to VISHNU.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check VISHNU.NS's competition here
Vishnu Chemicals Limited (BSE: VISHNU.BO)
ADVENZYMES.NS vs VISHNU.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, VISHNU.BO has a market cap of 42.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while VISHNU.BO trades at ₹631.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas VISHNU.BO's P/E ratio is 32.62. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to VISHNU.BO's ROE of +0.14%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to VISHNU.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check VISHNU.BO's competition here
Tatva Chintan Pharma Chem Limited (BSE: TATVA.BO)
ADVENZYMES.NS vs TATVA.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, TATVA.BO has a market cap of 40.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while TATVA.BO trades at ₹1,726.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas TATVA.BO's P/E ratio is 116.81. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to TATVA.BO's ROE of +0.07%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to TATVA.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check TATVA.BO's competition here
Tatva Chintan Pharma Chem Limited (NSE: TATVA.NS)
ADVENZYMES.NS vs TATVA.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, TATVA.NS has a market cap of 40.3B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while TATVA.NS trades at ₹1,722.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas TATVA.NS's P/E ratio is 91.13. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to TATVA.NS's ROE of +0.07%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to TATVA.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check TATVA.NS's competition here
Pondy Oxides And Chemicals Limited (NSE: POCL.NS)
ADVENZYMES.NS vs POCL.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, POCL.NS has a market cap of 40.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while POCL.NS trades at ₹526.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas POCL.NS's P/E ratio is 12.04. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to POCL.NS's ROE of +0.19%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to POCL.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check POCL.NS's competition here
Pondy Oxides And Chemicals Limited (BSE: POCL.BO)
ADVENZYMES.NS vs POCL.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, POCL.BO has a market cap of 40.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while POCL.BO trades at ₹525.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas POCL.BO's P/E ratio is 12.03. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to POCL.BO's ROE of +0.19%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to POCL.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check POCL.BO's competition here
Yasho Industries Limited (NSE: YASHO.NS)
ADVENZYMES.NS vs YASHO.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, YASHO.NS has a market cap of 37B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while YASHO.NS trades at ₹3,072.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas YASHO.NS's P/E ratio is 142.22. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to YASHO.NS's ROE of +0.06%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to YASHO.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check YASHO.NS's competition here
Yasho Industries Limited (BSE: YASHO.BO)
ADVENZYMES.NS vs YASHO.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, YASHO.BO has a market cap of 37B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while YASHO.BO trades at ₹3,069.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas YASHO.BO's P/E ratio is 146.53. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to YASHO.BO's ROE of +0.06%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to YASHO.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check YASHO.BO's competition here
Premier Explosives Limited (NSE: PREMEXPLN.NS)
ADVENZYMES.NS vs PREMEXPLN.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, PREMEXPLN.NS has a market cap of 35.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while PREMEXPLN.NS trades at ₹662.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas PREMEXPLN.NS's P/E ratio is 77.71. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to PREMEXPLN.NS's ROE of +0.17%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to PREMEXPLN.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check PREMEXPLN.NS's competition here
Premier Explosives Limited (BSE: PREMEXPLN.BO)
ADVENZYMES.NS vs PREMEXPLN.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, PREMEXPLN.BO has a market cap of 35.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while PREMEXPLN.BO trades at ₹662.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas PREMEXPLN.BO's P/E ratio is 124.10. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to PREMEXPLN.BO's ROE of +0.17%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to PREMEXPLN.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check PREMEXPLN.BO's competition here
Advanced Enzyme Technologies Limited (BSE: ADVENZYMES.BO)
ADVENZYMES.NS vs ADVENZYMES.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ADVENZYMES.BO has a market cap of 35.5B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ADVENZYMES.BO trades at ₹317.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ADVENZYMES.BO's P/E ratio is 22.53. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ADVENZYMES.BO's ROE of +0.11%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to ADVENZYMES.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ADVENZYMES.BO's competition here
Polyplex Corporation Limited (NSE: POLYPLEX.NS)
ADVENZYMES.NS vs POLYPLEX.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, POLYPLEX.NS has a market cap of 35.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while POLYPLEX.NS trades at ₹1,128.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas POLYPLEX.NS's P/E ratio is 12.08. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to POLYPLEX.NS's ROE of +0.01%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to POLYPLEX.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check POLYPLEX.NS's competition here
Polyplex Corporation Limited (BSE: POLYPLEX.BO)
ADVENZYMES.NS vs POLYPLEX.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, POLYPLEX.BO has a market cap of 35.4B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while POLYPLEX.BO trades at ₹1,130.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas POLYPLEX.BO's P/E ratio is 12.10. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to POLYPLEX.BO's ROE of +0.01%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to POLYPLEX.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check POLYPLEX.BO's competition here
Grauer & Weil (India) Limited (BSE: GRAUWEIL.BO)
ADVENZYMES.NS vs GRAUWEIL.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, GRAUWEIL.BO has a market cap of 33.6B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while GRAUWEIL.BO trades at ₹74.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas GRAUWEIL.BO's P/E ratio is 20.50. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to GRAUWEIL.BO's ROE of +0.16%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to GRAUWEIL.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check GRAUWEIL.BO's competition here
Grauer & Weil (India) Limited (NSE: GRAUWEIL.NS)
ADVENZYMES.NS vs GRAUWEIL.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, GRAUWEIL.NS has a market cap of 33.2B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while GRAUWEIL.NS trades at ₹73.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas GRAUWEIL.NS's P/E ratio is 20.49. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to GRAUWEIL.NS's ROE of +0.16%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to GRAUWEIL.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check GRAUWEIL.NS's competition here
Xpro India Limited (BSE: XPROINDIA.BO)
ADVENZYMES.NS vs XPROINDIA.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, XPROINDIA.BO has a market cap of 32.7B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while XPROINDIA.BO trades at ₹1,387.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas XPROINDIA.BO's P/E ratio is 169.06. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to XPROINDIA.BO's ROE of +0.03%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to XPROINDIA.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check XPROINDIA.BO's competition here
Xpro India Limited (NSE: XPROINDIA.NS)
ADVENZYMES.NS vs XPROINDIA.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, XPROINDIA.NS has a market cap of 32.5B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while XPROINDIA.NS trades at ₹1,386.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas XPROINDIA.NS's P/E ratio is 168.84. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to XPROINDIA.NS's ROE of +0.03%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to XPROINDIA.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check XPROINDIA.NS's competition here
Apcotex Industries Limited (BSE: APCOTEXIND.BO)
ADVENZYMES.NS vs APCOTEXIND.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, APCOTEXIND.BO has a market cap of 29.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while APCOTEXIND.BO trades at ₹560.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas APCOTEXIND.BO's P/E ratio is 28.62. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to APCOTEXIND.BO's ROE of +0.17%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to APCOTEXIND.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check APCOTEXIND.BO's competition here
Apcotex Industries Limited (NSE: APCOTEXIND.NS)
ADVENZYMES.NS vs APCOTEXIND.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, APCOTEXIND.NS has a market cap of 29.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while APCOTEXIND.NS trades at ₹561.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas APCOTEXIND.NS's P/E ratio is 28.67. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to APCOTEXIND.NS's ROE of +0.17%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to APCOTEXIND.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check APCOTEXIND.NS's competition here
Ddev Plastiks Industries Ltd. (NSE: DDEVPLSTIK.NS)
ADVENZYMES.NS vs DDEVPLSTIK.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, DDEVPLSTIK.NS has a market cap of 28.5B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while DDEVPLSTIK.NS trades at ₹275.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas DDEVPLSTIK.NS's P/E ratio is 27.73. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to DDEVPLSTIK.NS's ROE of +0.22%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to DDEVPLSTIK.NS. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check DDEVPLSTIK.NS's competition here
Ddev Plastiks Industries Limited (BSE: DDEVPLSTIK.BO)
ADVENZYMES.NS vs DDEVPLSTIK.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, DDEVPLSTIK.BO has a market cap of 28.5B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while DDEVPLSTIK.BO trades at ₹275.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas DDEVPLSTIK.BO's P/E ratio is 28.11. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to DDEVPLSTIK.BO's ROE of +0.06%. Regarding short-term risk, ADVENZYMES.NS is less volatile compared to DDEVPLSTIK.BO. This indicates lower risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check DDEVPLSTIK.BO's competition here
Jubilant Agri and Consumer Products Ltd. (NSE: JUBLCPL.NS)
ADVENZYMES.NS vs JUBLCPL.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, JUBLCPL.NS has a market cap of 28.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while JUBLCPL.NS trades at ₹1,851.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas JUBLCPL.NS's P/E ratio is 22.23. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to JUBLCPL.NS's ROE of +0.32%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to JUBLCPL.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check JUBLCPL.NS's competition here
Rossari Biotech Limited (NSE: ROSSARI.NS)
ADVENZYMES.NS vs ROSSARI.NS Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ROSSARI.NS has a market cap of 27.1B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ROSSARI.NS trades at ₹489.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ROSSARI.NS's P/E ratio is 18.17. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ROSSARI.NS's ROE of +0.12%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to ROSSARI.NS. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ROSSARI.NS's competition here
Rossari Biotech Limited (BSE: ROSSARI.BO)
ADVENZYMES.NS vs ROSSARI.BO Comparison July 2026
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES.NS) plays a significant role within the Basic Materials sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ADVENZYMES.NS stands at 35.5B. In comparison, ROSSARI.BO has a market cap of 26.9B. Regarding current trading prices, ADVENZYMES.NS is priced at ₹317.35 on the NSE, while ROSSARI.BO trades at ₹489.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ADVENZYMES.NS currently has a P/E ratio of 25.57, whereas ROSSARI.BO's P/E ratio is 18.18. In terms of profitability, ADVENZYMES.NS's ROE is +0.11%, compared to ROSSARI.BO's ROE of +0.12%. Regarding short-term risk, ADVENZYMES.NS is more volatile compared to ROSSARI.BO. This indicates higher risk in terms of short-term price fluctuations for ADVENZYMES.NS.Check ROSSARI.BO's competition here